| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/10/2013 | CA2840426A1 Use of anti-cd83 agonist antibodies for treating autoimmune diseases |
| 01/10/2013 | CA2840251A1 Combination therapy |
| 01/10/2013 | CA2840147A1 Polypeptide variants and uses thereof |
| 01/10/2013 | CA2840096A1 A process for detergent-free production of outer membrane vesicles of a gram-negative bacterium |
| 01/10/2013 | CA2839941A1 Recombinant low virulence bovine herpesvirus 1 (bohv-1) vaccine vectors |
| 01/10/2013 | CA2839513A1 Therapeutic combinations of anti - cd20 and anti - gm - csf antibodies and uses thereof |
| 01/10/2013 | CA2833946A1 Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells |
| 01/09/2013 | EP2543730A1 Antibody constant region variant |
| 01/09/2013 | EP2543680A1 Multispecific mutated antibody Fab fragments |
| 01/09/2013 | EP2543679A1 Antibodies for the treatment and prevention of thrombosis |
| 01/09/2013 | EP2543678A1 Antibodies for the treatment and prevention of thrombosis |
| 01/09/2013 | EP2543677A1 Antibodies for the treatment and prevention of thrombosis |
| 01/09/2013 | EP2543390A1 Pharmaceutical composition |
| 01/09/2013 | EP2543389A2 Methods and compositions inhibiting a lysyl oxidase (-like) protein for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 01/09/2013 | EP2543388A1 Drug for inflammatory bowel disease |
| 01/09/2013 | EP2543387A1 Mucosal vaccine |
| 01/09/2013 | EP2543386A1 Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure |
| 01/09/2013 | EP2543384A2 Treatment of conditions involving demyelination |
| 01/09/2013 | EP2542892A2 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 01/09/2013 | EP2542681A2 Protein and nucleic acid delivery vehicles, components and mechanisms thereof |
| 01/09/2013 | EP2542679A1 B-cell stimulating fusion proteins of an antigen with baff or april |
| 01/09/2013 | EP2542589A1 Anti-her2 antibodies and compositions |
| 01/09/2013 | EP2542588A1 Antibodies against human csf-1r and uses thereof |
| 01/09/2013 | EP2542584A2 Methods for treating pancreatic cancer |
| 01/09/2013 | EP2542583A2 Methods for treating breast cancer |
| 01/09/2013 | EP2542579A1 Biparatopic abeta binding polypeptides |
| 01/09/2013 | EP2542578A1 Smoc1, tenascin-c and brain cancers |
| 01/09/2013 | EP2542576A1 Methods for screening antibodies |
| 01/09/2013 | EP2542575A1 Expression of monoclonal antibodies in ciliate host cells |
| 01/09/2013 | EP2542571A1 Oligomer-specific amyloid beta epitope and antibodies |
| 01/09/2013 | EP2542566A2 Molecular clone of hiv-1 |
| 01/09/2013 | EP2542263A2 Ep1 inhibition |
| 01/09/2013 | EP2542262A1 Monoclonal antibodies directed to cd20 |
| 01/09/2013 | EP2542261A1 Antigen binding proteins specific for serum amyloid p component |
| 01/09/2013 | EP2542260A1 Recombinant attenuated parvovirus |
| 01/09/2013 | EP2542259A1 Avian group d rotavirus |
| 01/09/2013 | EP2542258A1 Monoclonal antibodies directed to cd52 |
| 01/09/2013 | EP2542257A1 Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
| 01/09/2013 | EP2542256A2 Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| 01/09/2013 | EP2542255A1 Methods and compositions for treating degos' disease |
| 01/09/2013 | EP2542252A1 Hiv-1 envelope based fragments |
| 01/09/2013 | EP2542221A2 Concentrated protein formulations and uses thereof |
| 01/09/2013 | EP2182981B1 Methods and compositions for treatment and diagnosis of fibrosis |
| 01/09/2013 | CN102869382A Composition for inhibiting hyperlipidemia and obesity by inhibiting intestinal absorption of cholesterol |
| 01/09/2013 | CN102869381A Drug for inflammatory bowel disease |
| 01/09/2013 | CN102869380A Live vaccine for aviary diseases |
| 01/09/2013 | CN102869379A Universal vaccine against H5N1 lineages |
| 01/09/2013 | CN102869378A 免疫原性组合物 The immunogenic composition |
| 01/09/2013 | CN102869377A 免疫原性组合物 The immunogenic composition |
| 01/09/2013 | CN102869376A Treatment of streptococcal infections |
| 01/09/2013 | CN102869375A Immunogenic composition comprising s. pneumoniae polysaccharides conjugated to carrier proteins |
| 01/09/2013 | CN102869374A Treatment of sleep disordered breathing with neurotoxin |
| 01/09/2013 | CN102869373A Albumin-free botulinum toxin formulations |
| 01/09/2013 | CN102869372A Modified tuberculosis antigens |
| 01/09/2013 | CN102869346A Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies |
| 01/09/2013 | CN102864157A Immune protective antigen of haemophilus parasuis |
| 01/09/2013 | CN102864151A Novel synthetic agonists of tlr9 |
| 01/09/2013 | CN102864130A Recombination influenza virus for high-efficiency expression HA (hemagglutinin) protein and preparation method and application thereof |
| 01/09/2013 | CN102864129A Recombinant influenza virus for efficiently expressing HA (Hemagglutinin) protein and preparation method as well as application thereof |
| 01/09/2013 | CN102864128A Recombinant influenza virus for efficiently expressing HA protein, and preparation method and application thereof |
| 01/09/2013 | CN102864127A Recombinant influenza virus for efficiently expressing HA (Hemagglutinin) protein and preparation method as well as application thereof |
| 01/09/2013 | CN102864090A Attenuated gram negative bacteria |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102863531A CD20-resistant monoclonal antibody as well as preparation method and application thereof |
| 01/09/2013 | CN102863528A Bovine-derived anti-staphylococcus aureus single-chain antibody, preparation method and application thereof |
| 01/09/2013 | CN102863527A Humanized hepatitis b virus resistance surface antigen gene engineering antibodies and preparation method and application thereof |
| 01/09/2013 | CN102863514A Peptide vaccines for cancers expressing tumor-associated antigens |
| 01/09/2013 | CN102861333A High-activity composite antibody oral preparation for resisting bursa fabricius viruses and influenza viruses of chicken |
| 01/09/2013 | CN102861332A Novel use of il-1beta compounds |
| 01/09/2013 | CN102861331A CD (cluster differentiation) 146 and application thereof to antibody diagnosis and treatment for inflammable diseases such as autoimmunity diseases |
| 01/09/2013 | CN102861330A Haemophilus influenzae type b (Hib) polysaccharide and refined tetanus toxoid coupling process |
| 01/09/2013 | CN102861329A Production method of canine parvovirus inactivated vaccine by utilizing bioreactor |
| 01/09/2013 | CN102861328A Novel foot-and-mouth disease vaccine and preparation method thereof |
| 01/09/2013 | CN102861327A Cell inactivated vaccine, egg yoke antibody and injection and freeze-dried powder containing same |
| 01/09/2013 | CN102861326A Epidemic encephalitis polysaccharide-protein conjugated vaccine and preparation method thereof |
| 01/09/2013 | CN102861325A Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 01/09/2013 | CN102861319A Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/09/2013 | CN102329746B Porcine streptococcus disease and haemophilus parasuis disease combined inactivated vaccine and preparation method thereof |
| 01/09/2013 | CN102302774B Peste des petits ruminants recombinant goat pox virus live vector vaccines |
| 01/09/2013 | CN102199611B Clostridium difficile exotoxin A carboxy-terminal gene sequence with optimized codon and nucleic acid vaccine thereof |
| 01/09/2013 | CN102166348B Application of inhibin recombinant fusion protein to preparing medicines for promoting oestrus and hybridization of sows |
| 01/09/2013 | CN102140139B Antitumor human single-chain antibody |
| 01/09/2013 | CN102008735B Small molecular DNA vaccine and preparation method thereof |
| 01/09/2013 | CN101948811B Method for expanding antigen spectrum of foot-and-mouth disease vaccine strain by reverse genetic operation and preparation method of vaccine |
| 01/09/2013 | CN101935349B Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/09/2013 | CN101824424B DNA vaccine based on B7-2-PE40 exotoxin fusion gene and application thereof |
| 01/09/2013 | CN101657214B Treatment or prophylaxis of asthma |
| 01/09/2013 | CN101591396B Anti-erbB2 human antibody MIL-5 and application thereof |
| 01/09/2013 | CN101268095B Bifunctional protein anchors |
| 01/08/2013 | USRE43914 Method for detecting syphilis using synthetic antigens |
| 01/08/2013 | US8350019 Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
| 01/08/2013 | US8350013 Using immunoaffinity separation to isolate preferential polypeptides in solution; large-scale preparation of proteins for therapeutics and/or diagnostics |
| 01/08/2013 | US8350011 Antibodies to ErbB2 |
| 01/08/2013 | US8350009 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; biomarkers |
| 01/08/2013 | US8350008 WISP polypeptides and nucleic acids encoding same |
| 01/08/2013 | US8349606 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 01/08/2013 | US8349569 Anti-fibronectin fragment monoclonal antibody |
| 01/08/2013 | US8349337 Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions |
| 01/08/2013 | US8349336 Streptococcus pyogenes antigens |
| 01/08/2013 | US8349334 Molecule |